Latest
finance.yahoo.com Earnings
Takeda Pharmaceutical (TSE:4502) Wins ORZEYFUL Approval, Where Does Fair Value Sit?
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Takeda Pharmaceutical (TSE:4502) has drawn fresh attention after U.S. regulators approved ORZEYFUL for adult narcolepsy type 1, and the company also issued new impairment guidance and reaffirmed its fiscal 2027 earnings outlook. See our latest analysis for Takeda …
Main company
🇦🇹 Austria
Read at finance.yahoo.com